Upregulation of p14arf has been identified in multiple hematological malignancies, aggressive types of B-cell lymphomas, and bladder cancers (Sánchez-Aguilera et al., 2002; Berggren et al., 2003; Lee et al., 2003). Here, CDKN2A is linked to B-cell non-Hodgkin lymphoma.